Align Technology Launches Treatment Planning Facility in Spain
The newly opened facility will add 130 jobs in 2018, provide local support to Invisalign trained doctors in Spain and Portugal
MADRID, Spain and SAN JOSE, Calif., Sept. 07, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDQ: ALGN), a global medical device company engaged in the design, manufacture and marketing of the Invisalign system and iTero intraoral scanners and services for orthodontic and restorative dentistry, announced today the launch of the new digital treatment planning facility and education centre in Madrid, Spain. The new launch reflects the dynamic growth of Spain and Portugal (jointly known as Iberia) in the EMEA region and beyond. Iberia is the third largest Invisalign market worldwide (after North America and China), growing dynamically year on year.
The second of its kind in Europe and the fourth worldwide, the treatment planning facility in Madrid aims to increase the company’s commitment to Invisalign trained doctors in Spain and Portugal, and will play a key role in Align Technology`s strategy to be closer to its customers and support them in digital treatment planning. The new facility, which will also act as education centre for doctors, will bring together current commercial teams representing Iberia and the new treatment planning team to provide Spanish and Portuguese doctors with first-hand support from the local staff. The new 3,500 square meter office will host 185 employees by the end of 2018 – a significant increase from the 10 employees employed in Spain since 2013.
“Since we launched our operations in the country 17 years ago, we have seen continuous growth and have played an important role in expanding Align’s operations in the EMEA region,” explained Juan Manuel Frade, Align Technology general manager, Iberia. “The city of Madrid offers a vibrant ecosystem for innovative companies, while our new facilities support Align`s efforts to offer first-hand local support to Spanish and Portuguese dental professionals, helping them achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients.”
The state-of-the-art facilities in Madrid will serve as commercial and operations site for the entire Iberia business. Align Technology, as a global medical company, works directly with doctors across both countries to provide them with the Invisalign system of clear aligners that doctors prescribe to their patients to straighten their teeth. The new facilities will provide Invisalign trained doctors with closer, more personalized support to ensure they in turn can offer improved service to their patients.
“Our newly opened facility in Madrid is an important step forward in bringing our technology closer to Invisalign doctors, in a time of growing demand for clear aligner therapy from both consumers and doctors,” said Emory Wright, senior vice president, global operations. “This facility will allow us to directly support the orthodontists in Iberia in their effort to continue to achieve greater clinical outcomes in teeth straightening. The in-region expertise and localization of services in strategic markets is necessary for us to be able to serve the growing needs of the doctors for local support.”
The treatment planning facility will be equipped with the latest technology, including Align Technology’s proprietary software which makes it possible to create a customized treatment for each patient. The new treatment planning facilities are part of the 100 million dollar global investment that the company expects to make this year, and will enable the Madrid site to offer some of the most innovative orthodontic solutions in the region.
“We are extremely proud to be launching our second European treatment planning facility in Madrid. It spearheads the technological innovation within the clear aligner field, placing Spain and Portugal at the forefront of the digital future of orthodontics in Europe,” said Simon Beard, Align Technology senior vice president and managing director, EMEA. “Iberia continues dynamic business growth, being the strongest contributor to Align Technology’s 38% growth across EMEA last year. I am confident our expansion of the infrastructure and the geographical coverage will continue to deliver exceptional results and will help us strengthen our relations with Invisalign trained doctors in the region.”
The company officially opened the new facility today during a ceremony attended by Invisalign trained doctors from Spain, media and dental associations.
Clear aligners are a removable and transparent teeth-straightening solution produced using digital and 3D technologies. This type of solution differs from other orthodontic devices in that they are more comfortable and can be easily removed for eating or drinking. Used to treat minor to complex types of malocclusions, clear aligners are replaced every one or two weeks, depending on a doctor`s recommendation, gradually moving teeth towards the projected final position.
Digital treatments are created at Align Technology’s treatment planning facilities by CAD designers, following doctors’ guidelines and instructions. The new treatment planning facility represents a milestone in Align’s expansion in Iberia that will ensure that doctors in the region, which are already supported by local clinical and customer support teams, also benefit from the presence of local CAD designers, enabling doctors to offer an improved service to their own patients.
About Align Technology, Inc.
Align Technology is a global medical device company engaged in the design, manufacture and marketing the most advanced clear aligner system in the world and intraoral scanners and services for orthodontic and restorative dentistry. Align’s products help dental professionals achieve the clinical results they expect and deliver effective dental options to their patients. Visit www.aligntech.es or more information.
+31 6211 434 20
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg saker fra GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra GlobeNewswire
Real World Cloud Orchestration Facilitates Easy Migration to All-IP18.4.2019 22:05:00 CEST | Pressemelding
For All-IP service providers in Malta and the Netherlands, Patton Cloud edge orchestration has lowered costs with fast, simple activation and management of enterprise IP-Telephony services SmartNode VoIP… More than Just Talk! BERN, Switzerland, April 18, 2019 (GLOBE NEWSWIRE) -- Patton—a U.S. network-equipment manufacturer and multi-national provider of enabling solutions for virtualized network function virtualization (NFV) SD-WAN, All-IP, and unified communications (UC) services—has saved the day for Dutch and Maltese national IP-communications providers with its Patton Cloud network edge orchestration service. VIDEO: Cloud Powered Services Netherlands ISDN Services are going away in the Netherlands. Yet scores of business subscribers can't simply jump into an All-IP network overnight. Investments in ISDN-based systems, fused with established business-processes, preclude such reckless dismantling of on-premise legacy systems. Business customers need flexibility to manage migration to
Acreage Holdings Announces Signing of Arrangement Agreement18.4.2019 17:02:00 CEST | Pressemelding
FRANKFURT, Germany, April 18, 2019 (GLOBE NEWSWIRE) -- Acreage Holdings, Inc. (“Acreage”) (CSE:ACRG.U) (OTC:ACRGF) (FSE:0VZ) and Canopy Growth Corporation (“Canopy Growth”) (TSX:WEED) (NYSE:CGC) (together, the “Companies”) entered into a definitive arrangement agreement (the "Agreement") that grants Canopy Growth the right to acquire 100 percent of the shares of Acreage (the “Right”), with a requirement to do so at such time as cannabis production and sale becomes federally legal in the United States of America (the "Transaction"), subject to obtaining the requisite prior approval of the shareholders of each of Acreage and Canopy Growth, respectively (the “Shareholder Approval”), as well as the approval of the Supreme Court of British Columbia, Canada (the “Court Approval”). Following the Shareholder Approval and the Court Approval, under the terms of the Agreement, and upon exercise of the Right, the total consideration payable pursuant to the Transaction is valued at approximatel
WillScot to Participate at the Credit Suisse Extreme Services Conference18.4.2019 16:19:00 CEST | Pressemelding
BALTIMORE, April 18, 2019 (GLOBE NEWSWIRE) -- WillScot Corporation (“WillScot”) (NASDAQ: WSC), the specialty rental services market leader providing innovative modular space and portable storage solutions across North America, today announced that Brad Soultz, President and Chief Executive Officer, and Tim Boswell, Chief Financial Officer, will host a day of one-on-one and group meetings with investors at the Credit Suisse Extreme Services Conference to be held at Credit Suisse’s New York City office, on Tuesday, May 7, 2019. About WillScot Corporation Headquartered in Baltimore, Maryland, WillScot is the public holding company for the Williams Scotsman family of companies. WillScot trades on the Nasdaq stock exchange under the ticker symbol "WSC," and is the specialty rental services market leader providing innovative modular space and portable storage solutions across North America. WillScot is the modular space supplier of choice for the construction, education, health care, governm
TrueCommerce Datalliance Releases First Platform Update of 201918.4.2019 16:00:00 CEST | Pressemelding
Supply chain software company expands self-service options, more control for customers’ data CINCINNATI, April 18, 2019 (GLOBE NEWSWIRE) -- TrueCommerce, a global provider of trading partner connectivity, integration and unified commerce solutions, has announced today that TrueCommerce Datalliance, its division focusing on vendor managed inventory (VMI) and collaborative replenishment (CR) software, has released its first of three software updates for 2019. In addition to general reliability and stability fixes, the update provides customers with more control over updating specific fields and who has access to that information, as well as adding store-driven demand. Doug Bethea, Vice President of Consumer Goods Solutions said, “Every update is multifaceted. We implement necessary security changes and adjust code to optimize performance for our customers. We also bring our own ideas as value-adds. Additionally, we are always working with customers to implement advanced features as it is
Constellation Brands Enters Into Agreement with Canopy Growth Corporation to Modify Warrants and Other Rights18.4.2019 15:33:00 CEST | Pressemelding
VICTOR, N.Y., April 18, 2019 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, today announced that it plans to enter into an agreement with Canopy Growth Corporation (“Canopy”) (TSX: WEED, NYSE: CGC), a leading diversified cannabis company, to modify certain warrants and other rights. These changes are the result of Canopy’s intentions to acquire Acreage Holdings, Inc. (“Acreage”) upon U.S. Federal cannabis legalization. Earlier today, Canopy announced (see Canopy press release “Canopy Growth Announces Option to Acquire Leading U.S. Multi-state Cannabis Operator, Acreage Holdings”) it has entered into an agreement with Acreage, a U.S. multi-state cannabis operator, where Canopy plans to acquire the shares of Acreage upon U.S. Federal cannabis legalization (the “Triggering Event”), subject to certain conditions. This transaction, as well as proposed modifications to certain Constellation warrants, are subject to approval by Canopy
Resverlogix’ BETonMACE Phase 3 Trial Successfully Reaches its Targeted 250 MACE Events18.4.2019 14:00:00 CEST | Pressemelding
World’s First Phase 3 BET Bromodomain Epigenetics Trial Reaches Events Target CALGARY, Alberta, April 18, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) today announces that BETonMACE, the Company’s event-based, phase 3 registration trial has successfully reached 250 projected major adverse cardiac events (MACE), strictly defined as cardiovascular death, non-fatal myocardial infarction and stroke, moving the trial towards completion. Successful data from this trial would enable Resverlogix to proceed towards the regulatory approval and commercialization of its lead drug, apabetalone. “Resverlogix staff and stakeholders have worked diligently for the past 18 years to attain this extremely exciting goal,” said Donald McCaffrey, President and CEO of Resverlogix. “The trial’s extensive breakthrough clinical data will soon be available to Resverlogix. Successfully meeting the trial’s endpoints, the substantial data set and otherwise new findings would